非手术候选者中相对适应证早期胃癌内镜黏膜下剥离术后的长期结局
在一个西方大型单中心前瞻性队列中,149例平均年龄73.7岁的老年合并症患者因早期胃癌接受内镜黏膜下剥离术(ESD)共157例。中位随访51.6个月,绝对适应证与相对适应证(RI)早期胃癌的5年总生存率(88.9% vs 77.9%,P=.290)和无病生存率(83.2% vs 75.1%,P=.593)均无显著差异。绝对适应证组的整块切除率(96.3% vs 87.5%,P=.069)和R0切除率(93.6% vs 62.5%,P<.001)高于RI组,严重不良事件无显著差异(7.3% vs 12.5%,P=.363)。
要点
- 绝对适应证与相对适应证早期胃癌ESD后5年总生存率和无病生存率无显著差异。
- 绝对适应证组R0切除率高于相对适应证组(93.6% vs 62.5%,P<.001)。
- 两组严重不良事件无显著差异,且无因ESD不良事件导致的死亡或手术切除。
核心结论
- 在西方大型队列中,ESD可安全地为相对适应证早期胃癌的手术条件差的患者提供无病生存。
- 年老和/或合并症或拒绝手术切除的患者可能从ESD获益,并避免手术风险及其长期后遗症。
研究设计与样本
- 单中心前瞻性分析,连续纳入10年间在一家西方三级内镜中心因早期胃癌接受ESD的患者。
- 共149例患者、157例早期胃癌,平均年龄73.7岁,年龄校正Charlson合并症指数4.2。
- 主要结局为长达5年的长期总生存率和无病生存率,次要结局为疗效和严重不良事件。
主要发现
- 中位随访51.6个月,绝对适应证与相对适应证早期胃癌的5年总生存率分别为88.9%和77.9%(P=.290),无显著差异。
- 绝对适应证与相对适应证早期胃癌的5年无病生存率分别为83.2%和75.1%(P=.593),无显著差异。
- 绝对适应证组整块切除率为96.3%,相对适应证组为87.5%(P=.069)。
- 绝对适应证组R0切除率为93.6%,相对适应证组为62.5%(P<.001)。
- 绝对适应证组严重不良事件发生率为7.3%,相对适应证组为12.5%(P=.363),无显著差异;无因ESD不良事件导致的死亡或手术切除。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Endoscopic submucosal dissection (ESD) is effective in treating early gastric cancer (EGC). Its role in patients with comorbidities along with more advanced disease is unknown. We sought to evaluate this in a large Western cohort. METHODS: Consecutive patients who underwent ESD for EGC in a single tertiary Western endoscopy center over 10 years were prospectively analyzed. The primary outcomes were long-term overall survival (OS) and disease-free survival (DFS) up to 5 years. Secondary outcomes were efficacy and serious adverse events (SAEs). RESULTS: ESD for 157 cases of EGC in 149 patients was performed in an elderly and comorbid cohort with a mean age of 73.7 years and age-adjusted Charlson Comorbidity Index of 4.2. Over a median follow-up of 51.6 months, no significant differences were found in 5-year OS (88.9% vs 77.9%, P = .290) and DFS (83.2% vs 75.1%, P = .593) between absolute indication EGC and relative indication (RI) EGC. The absolute indication EGC cohort achieved higher en bloc (96.3% vs 87.5%, P = .069) and R0 resection rates (93.6% vs 62.5%, P < .001) when compared with RI EGC. No significant differences were found in SAEs (7.3% vs 12.5%, P = .363). No mortality or surgical resection ensued from adverse events from ESD. CONCLUSIONS: ESD safely confers DFS in poor surgical candidates with RI EGC in a large Western cohort. Patients who are elderly and/or with comorbidities or who decline surgical resection may benefit from ESD and avoid the risks of surgery and its long-term sequelae. (Clinical trial registration number: NCT02306707.).
引用
- Wang H, Nguyen M, Gupta S, et al. Long-term outcomes after endoscopic submucosal dissection for relative indication early gastric cancer in nonsurgical candidates. Gastrointest Endosc. 2024. PMID: 38580133. doi:10.1016/j.gie.2024.03.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。